Skip to main content
. 2024 Mar 28;21(3):e1004352. doi: 10.1371/journal.pmed.1004352

Table 1. Descriptive statistics of baseline characteristics, by treatment group, based on the FA set.

Continuous variables are given by mean (SD) (normal data) or median (IQR) (non-normal data). Categorical variables are given by numbers (percentages).

Baseline characteristic Total (n = 249) Hyoscine butylbromide (n = 125) Placebo (n = 124)
Maternal age (in years)
 Mean (SD) 32.0 (4.0) 31.7 (4.4) 32.3 (3.6)
Maternal age (in years)
 <25 8 (3.2%) 6 (4.8%) 2 (1.6%)
 25–29 55 (22.1%) 31 (24.8%) 24 (19.4%)
 30–34 124 (49.8%) 59 (47.2%) 65 (52.4%)
 ≥35 62 (24.9%) 29 (23.2%) 33 (26.6%)
Maternal height (in cm)
 Mean (SD) 167.1 (6.7) 167.0 (6.6) 167.2 (6.8)
Maternal weight (in kg)
 Median (IQR) 62.0 (12.0) 61.0 (11.0) 63.0 (14.0)
Maternal BMI (in kg/m 2 )
 <18.5 9 (3.6%) 7 (5.6%) 2 (1.6%)
 18.5–24.9 188 (75.5%) 97 (77.6%) 91 (73.4%)
 25.0–29.9 39 (15.7%) 16 (12.8%) 23 (18.5%)
 ≥30.0 13 (5.2%) 5 (4.0%) 8 (6.5%)
Maternal marital status
 Married 87 (34.9%) 47 (37.6%) 40 (32.3%)
 Cohabiting 150 (60.2%) 70 (56.0%) 80 (64.5%)
 Single 10 (4.0%) 7 (5.6%) 3 (2.4%)
 Unknown 2 (0.8%) 1 (0.8%) 1 (0.8%)
Maternal higher education
 No 13 (5.2%) 4 (3.2%) 9 (7.3%)
 Yes 234 (94.0%) 119 (95.2%) 115 (92.7%)
 Missing 2 (0.8%) 2 (1.6%) 0 (0.0%)
Maternal chronic diseases
 No 157 (63.1%) 82 (65.6%) 75 (60.5%)
 Yes 91 (36.5%) 43 (34.4%) 48 (38.7%)
 Missing 1 (0.4%) 0 (0.0%) 1 (0.8%)
Maternal medication during pregnancy
 No 150 (60.2%) 82 (65.6%) 68 (54.8%)
 Yes 99 (39.8%) 43 (34.4%) 56 (45.2%)
Maternal pain score at baseline
 Median (IQR) 3.0 (5.0) 3.0 (5.0) 3.0 (5.0)
 Missing 1 (0.4%) 0 (0.0%) 1 (0.8%)
Maternal heart rate at baseline (in beats/min)
 Mean (SD) 86.5 (14.9) 87.5 (15.7) 85.4 (13.9)
Fetal heart rate at baseline (in beats/min)
 Mean (SD) 139.8 (10.5) 139.6 (10.2) 139.9 (10.9)
Cervical dilation at baseline (in cm)
 Median (IQR) 5.0 (2.0) 5.0 (2.0) 5.0 (2.0)

BMI, body mass index; FA, full analysis; IQR, interquartile range; SD, standard deviation.